TY  - JOUR
AU  - Fernandez, Agustin F
AU  - Bayon, Gustavo F
AU  - Sierra, Marta I
AU  - Urdinguio, Rocio G
AU  - Toraño, Estela G
AU  - Garcia, Maria G
AU  - Carella, Antonella
AU  - Lopez, Virginia
AU  - Santamarina, Pablo
AU  - Perez, Raul F
AU  - Belmonte, Thalia
AU  - Tejedor, Juan Ramon
AU  - Cobo, Isabel
AU  - Menendez, Pablo
AU  - Mangas, Cristina
AU  - Ferrero, Cecilia
AU  - Rodrigo, Luis
AU  - Astudillo, Aurora
AU  - Ortea, Ignacio
AU  - Cueto Diaz, Sergio
AU  - Rodriguez-Gonzalez, Pablo
AU  - Garcia Alonso, J Ignacio
AU  - Mollejo, Manuela
AU  - Melendez, Barbara
AU  - Dominguez, Gemma
AU  - Bonilla, Felix
AU  - Fraga, Mario F
PY  - 2018
DO  - 10.1093/hmg/ddy214
UR  - http://hdl.handle.net/10668/12561
T2  - Human molecular genetics
AB  - Aberrant DNA hypermethylation is a hallmark of cancer although the underlying molecular mechanisms are still poorly understood. To study the possible role of 5-hydroxymethylcytosine (5hmC) in this process we analyzed the global and locus-specific...
LA  - en
PB  - Oxford University Press
KW  - 5-Methylcytosine
KW  - Biomarkers, tumor
KW  - Case-control studies
KW  - CpG islands
KW  - DNA methylation
KW  - Epigenesis, genetic
KW  - Gene expression regulation, neoplastic
KW  - Genome, human
KW  - Glioma
KW  - Humans
TI  - Loss of 5hmC identifies a new type of aberrant DNA hypermethylation in glioma.
TY  - research article
VL  - 27
ER  -